昭
06127
昭衍新藥
20.320
+2.090+11.46%Closed16:08 07/10 HKT
OPEN/PREV CLOSE25.000/22.200
TODAY RANGE23.160-28.940
VOL62.79M
MARKET CAP20.59B
52 WEEK RANGE15.026-28.940
AVG VOL (3M)5.08M
% TURNOVER8.38%
TURNOVER1.66B
P/E (TTM)36.723
% RANGE26.04%
EPS(TTM)0.748
P/E(FORWARD)40.972
P/B2.125
BVPS12.933
DIVIDEND0.138
P/S10.781
BETA--
DIV YIELD0.50%
FREE FLOAT MKT CAP3.27B
SHARES OUTSTANDING749.35M
NEXT EARNINGS08/24-08/28
FREE FLOAT119.00M
LOT SIZE100
EX-DATE06/22/2026
News
Press Releases
Financial Reports
Profile
PUBT·05/12 10:52
Joinn Laboratories announces 2026 first H share class meeting
PUBT·04/29 10:37
Joinn Laboratories publishes 2025 annual report
Reuters·04/29 10:13
BRIEF-JOINN Posts Q1 Net Income Attributable RMB 238.4 Million
Reuters·03/30 13:14
Joinn Laboratories proposes final dividend of RMB 0.12 per share
Reuters·12/05/2025 13:58
JOINN Laboratories (CA) Expands Non-Clinical Research Operations in United States
Reuters·12/05/2025 13:57
Joinn Laboratories China Files Director List with HKEX
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.